Knight Therapeutics (04K) Q2 2026 Earnings Report
DE:04K Q2 2026 EPS Results
- Actual EPS
- -EUR 0.02
- Consensus EPS
- EUR 0.01
- Beat/Miss
- Missed by -EUR 0.03
- One Year Ago EPS
- -EUR 0.08
DE:04K Q2 2026 Revenue Results
- Actual Revenue
- EUR 92.40M
- Expected Revenue
- EUR 80.97M
- Beat/Miss
- Beat by +EUR 11.43M
- YoY Revenue Growth
- +34.33%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/06/2026
- Time
- Before Open
- Conference Call
- Thursday, August 6, 2026
DE:04K Upcoming Earnings
Knight Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:04K Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:04K Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | 0.01- | -0.03 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | 0.01-0.02 | -0.08 | 76.92% (+0.06) | |
| May 07, 2026 | 2026 (Q1) | 0.010.08 | 0.01 | 550.00% (+0.07) | |
| Mar 19, 2026 | 2025 (Q4) | -0.000.06 | 0.07 | -18.18% (-0.01) | |
| Nov 06, 2025 | 2025 (Q3) | -0.00-0.03 | 0 | ― | |
| Aug 07, 2025 | 2025 (Q2) | 0.01-0.08 | -0.01 | -550.00% (-0.07) | |
| May 08, 2025 | 2025 (Q1) | 0.000.01 | -0.03 | 150.00% (+0.04) | |
| Mar 20, 2025 | 2024 (Q4) | 0.010.07 | -0.15 | 147.83% (+0.22) | |
| Nov 07, 2024 | 2024 (Q3) | 0.010.00 | 0.06 | -100.00% (-0.06) | |
| Aug 08, 2024 | 2024 (Q2) | 0.02-0.01 | 0.01 | -200.00% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
